Compound suggests pain treatment without opioid or medical marijuana side effects

November 14, 2016
Andrea Hohmann. Credit: Indiana University

Indiana University neuroscientist Andrea Hohmann took the stage at a press conference Nov. 14 in San Diego to discuss research conducted at IU that has found evidence that the brain's cannabis receptors may be used to treat chronic pain without the side effects associated with opioid-based pain relievers or medical marijuana.

The study was discussed during the annual meeting of the Society for Neuroscience, the world's largest source of emerging news about brain science and health. Hohmann was joined by three other international researchers whose work focuses on similar topics.

"The most exciting aspect of this research is the potential to produce the same therapeutic benefits as opioid-based without like addiction risk or increased tolerance over time," said Hohmann, a Linda and Jack Gill Chair of Neuroscience and professor in the IU Bloomington College of Arts and Sciences' Department of Psychological and Brain Sciences.

Chronic pain is estimated to affect nearly 50 million adults in the United States. The rise in opioid-based pain relievers to treat chronic pain has also contributed to an opioid addiction epidemic in the United States, with 19,000 deaths linked to prescription opioid abuse in 2014. In Indiana, the use of needles associated with prescription opioid abuse led to a major HIV outbreak in the state's southeastern region, prompting the governor to declare a in 2015.

"The fact that deaths associated with prescription opioid abuse have surpassed cocaine and heroin overdose deaths combined is a significant factor in exploring cannabinoids as an alternative treatment for pain," said Richard Slivicki, a graduate student in Hohmann's lab who led the study. "It's a major epidemiological crisis, and one that helps motivate our work."

The IU study found that a compound that modulates the activity of the brain's receptors for THC and endocannabinoids reduced chronic pain in mice. THC, or tetrahydrocannabinol, is the main psychoactive ingredient in marijuana; endocannabinoids are natural pain-relieving compounds released by the brain.

These modulating compounds, called positive allosteric modulators, or PAMs, work by binding to a recently discovered site on a cannabinoid receptor in the brain called CB1, which is different from the site that binds THC. The PAMs were synthesized by Ganesh A. Thakur at Northeastern University, who is a collaborator on the study.

The IU scientists specifically tested the effects of CB1 PAM on , a type of caused by nerve damage, which is estimated to affect as many as 40 percent of cancer patients as a side effect of chemotherapy. The scientists gave mice paclitaxel, a chemotherapy drug known to damage nerves and cause pain, and then treated them with CB1 PAM.

After receiving paclitaxel, mice became hypersensitive to both mechanical and cold stimulations to the paw, indicating increased pain. After treatment with the CB1 PAM, the mice behaved like normal mice that did not experience pain.

The study also found evidence that the use of CB1 PAM amplified the therapeutic effect of endocannabinoids without the negative side effects of a "marijuana high," such as impaired motor function. The PAMs were administered in combination with a compound to increase endocannabinoid levels in the brain by preventing their breakdown in the body.

Moreover, the team found that the use of the CB1 PAM remained effective over time to prevent in mice, as opposed to THC and endocannabinoid breakdown inhibitors, both of which stopped working with repeated dosing.

"We found that the compound did not produce reward on its own, so it's unlikely that a CB1 PAM would be abused as a recreational drug," Hohmann added. "Our studies show that we can maintain or preserve therapeutic efficacy in ways that we haven't seen with some of the other classes of analgesics that are used in the clinic."

The other scientists at the press conference, who were not involved in the study, were Sabrina Lisboa of the University of São Paolo, Brazil; Jason Clapper of Abide Therapeutics, San Diego; and Maria S. García-Gutiérrez of Miguel Hernandez University, Spain. The event was titled "Targeting the Brain's Cannabinoid System."

Explore further: An alternative to medical marijuana for pain?

Related Stories

An alternative to medical marijuana for pain?

March 4, 2015
Medical marijuana is proliferating across the country due to the ability of cannabis ingestion to treat important clinical problems such as chronic pain. However, negative side effects and the development of tolerance limit ...

DEA puts quota on production of opioid painkillers

October 6, 2016
(HealthDay)—The U.S. Drug Enforcement Administration (DEA) says it has mandated significant cuts in the production of powerful prescription opioid painkillers.

Opioid receptors outside the brain targeted in rats; new direction for painkillers

August 25, 2016
Opioid abuse is a growing public health crisis, affecting up to 36 million people worldwide. Many of these individuals first get hooked on prescription painkillers that target mu opioid receptors in the brain. A study in ...

Physical therapy is best choice for pain management

August 29, 2016
According to the Centers for Disease Control and Prevention (CDC), sales of prescription opioids have quadrupled in the United States since 1999, even though there has not been an overall change in the amount of pain reported.

New drug target could prevent tolerance and addiction to opioids, neuroscience study finds

August 22, 2016
Researchers have identified a brain mechanism that could be a drug target to help prevent tolerance and addiction to opioid pain medication, such as morphine, according to a study by Georgia State University and Emory University.

Study finds many patients abusing drugs and alcohol are self-medicating chronic pain

May 9, 2016
With opioid addiction and prescription drug abuse considered one of the biggest public health threats of our time in the U.S., many are asking why so many Americans are struggling with addiction to illegal drugs and prescription ...

Recommended for you

How a seahorse-shaped brain structure may help us recognize others

December 8, 2017
How do we recognize others? How do we know friend from foe, threat from reward? How does the brain compute the multitude of cues telling us that Susan is not Erica even though they look alike? The complexity of social interactions—human ...

Brain networks that help babies learn to walk ID'd

December 8, 2017
Scientists have identified brain networks involved in a baby's learning to walk—a discovery that eventually may help predict whether infants are at risk for autism.

Why we can't always stop what we've started

December 7, 2017
When we try to stop a body movement at the last second, perhaps to keep ourselves from stepping on what we just realized was ice, we can't always do it—and Johns Hopkins University neuroscientists have figured out why.

Mutations in neurons accumulate as we age: The process may explain normal cognitive decline and neurodegeneration

December 7, 2017
Scientists have wondered whether somatic (non-inherited) mutations play a role in aging and brain degeneration, but until recently there was no good technology to test this idea. A study published online today in Science, ...

Researchers launch atlas of developing human brain

December 7, 2017
The human brain has been called the most complex object in the cosmos, with 86 billion intricately interconnected neurons and an equivalent number of supportive glial cells. One of science's greatest mysteries is how an organ ...

How we learn: Mastering the features around you rather than learning about individual objects

December 7, 2017
A Dartmouth-led study on how we learn finds that humans tend to rely on learning about the features of an object, rather than on the individual object itself.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Thnder
5 / 5 (1) Nov 15, 2016
'negative side effects of a "marijuana high,"'
I don't see that as a negative. If you are an adult, who cares...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.